Why Tonix Pharmaceuticals Stock Dived by Over 31% Today

Why Tonix Pharmaceuticals Stock Dived by Over 31% Today

All stocks have bad days at least once in a while, but Monday for Tonix Pharmaceuticals (NASDAQ: TNXP) was one of the ugliest trading sessions in its history. The company's stock lost nearly one-third of its value after the company announced a financial engineering move that sent investors scrambling for the exits. Tonix announced Monday afternoon that it is effecting a 1-for-32 reverse split of its common stock.